NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000055838

Registered date:03/01/2025

A retrospective clinical study on the prognosis and incidence of fractures between calcimimetics users and non-users in dialysis patients with achievement of PTH management target value

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedPatients with end-stage kidney disease undergoing hemodialysis and online hemodiafiltration
Date of first enrollment2024/11/01
Target sample size500
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary Outcome2-year all-cause mortality
Secondary Outcome2-year incidence of fractures

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1 Use of dialyzers with beta2-microgloburln clearance below 70 mL/min 2 Missing data for covariates at study entry 3 Dialysis conditionssuch as dialysis method and membrane material between April 1, 2017 and June 30, 2017, which are different from those as of July 1, 2017 4 Blood purification methods other than hemodialysis and online hemodiafiltration 5 Dialysis frequency below 3 sessions per week or dialysis time below 3 hour per session 6 Pregnant or lactating patients 7 Patients with below 60pg/mL or over PTH 241pg/mL

Related Information

Contact

public contact
Name Manabu Tashiro
Address 6-1 Kitasako ichiban-cho, Tokushima-shi, Tokushima,Japan Japan 7700011
Telephone 0886310110
E-mail m.tashiro@khg.or.jp
Affiliation Social medical corporation Kawashimakai Kawashima Hospital Department of Nephrology
scientific contact
Name Kazuyoshi Okada
Address 6-1 Kitasako ichiban-cho, Tokushima-shi, Tokushima, J Japan
Telephone 088-631-0110
E-mail kokada@minos.ocn.ne.jp
Affiliation Social medical corporation Kawashimakai Kawashima Hospital Blood purification management center